Dreavent
Finance · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1 Kendall Sq, Cambridge, Massachusetts, ...Website
www.dreaventcapital.comRevenue
<$5 MillionIndustry
About Dreavent
Dreavent Capital is a strategic investment firm specializing in funding innovative biopharma companies focused on developing cures for various health conditions. The firm aims to invest in 5-6 companies annually through its Dreavent Engine 2026 fund, targeting a total of $210 million by 2026. With over 14 years of experience in the Boston biotech ecosystem, it actively collaborates with leading pharmaceutical companies and investment groups to foster growth in oncology, neurology, cardiovascular, metabolic, and immunology sectors. Dreavent is dedicated to transforming cutting-edge scientific research into effective patient treatments, driving healthcare progress through strategic investments in the biopharma landscape.Explore more
Dreavent Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Dreavent
Compare insights from companies similar to Dreavent, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Dreavent Tech Stack
A closer look at the technologies used by Dreavent
Top Finance Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Dreavent
Sign Up For FreeTo access detailed company insights
Dreavent Capital is a strategic investment firm specializing in funding innovative biopharma companies focused on developing cures for various health conditions. The firm aims to invest in 5-6 companies annually through its Dreavent Engine 2026 fund, targeting a total of $210 million by 2026. With over 14 years of experience in the Boston biotech e... Read More
